Citigroup Maintains Buy on FormFactor, Lowers Price Target to $42
Citigroup analyst Amanda Scarnati maintains FormFactor (NASDAQ:FORM) with a Buy and lowers the price target from $45 to $42.
This Healthcare Stock Tumbled 43%; Here Are 88 Biggest Movers From Yesterday
Gainers
Athersys, Inc. (NASDAQ: ATHX) climbed 71.1% to close at $0.3250 on Thursday after gaining 10% on Wednesday. Athersys is expected to release its Q2 financial results on Thursday, August 11, 2022.
Earnings Scheduled For July 27, 2022
Companies Reporting Before The Bell
• Equinor (NYSE:EQNR) is projected to report earnings for its second quarter.
B. Riley Securities Maintains Buy on FormFactor, Lowers Price Target to $48
B. Riley Securities analyst Craig Ellis maintains FormFactor (NASDAQ:FORM) with a Buy and lowers the price target from $55 to $48.
Earnings Scheduled For April 27, 2022
Companies Reporting Before The Bell
• Deutsche Bank (NYSE:DB) is projected to report earnings for its first quarter.
Stifel Maintains Buy on FormFactor, Lowers Price Target to $47
Stifel analyst Brian Chin maintains FormFactor (NASDAQ:FORM) with a Buy and lowers the price target from $51 to $47.
FormFactor Q4 EPS $0.44 Beats $0.41 Estimate, Sales $205.00M Beat $198.17M Estimate
FormFactor (NASDAQ:FORM) reported quarterly earnings of $0.44 per share which beat the analyst consensus estimate of $0.41 by 7.32 percent. This is unchanged from the same period last year. The company reported